BM-MSC/TERT2922022-12-21T12:13:24+00:00

Bone marrow

BM-MSC/TERT292

Evercyte ́s BM-MSC/TERT292 cell line has been developed from bone marrow-derived mesenchymal stromal cells, can be grown without limitations, shows typical markers and functions of MSCs and therefore represents a valuable model for studying processes such as differentiation, inflammation, tissue homeostasis and repair. In recent years evidence has accumulated that the potency of mesenchymal stem cells at least in part is mediated by secreted extracellular vesicles (EVs). BM-MSC/TERT292 cell line has been established under conditions that will allow production of EVs for clinical applications.

Print Friendly, PDF & Email

from

€ 1300,–

BM-MSC/TERT292
Cat#: CHT-063-0292

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Related Products

extracellular vesicles from bone marrow-derived MSCs

EV-BM-MSC/TERT292

ASC/TERT300

adipose-derived mesenchymal stem cells / EV cell factory

Related Services

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

Related Products

mesenchymal stromal cells for production of clinical grade extracellular vesicles

Related Services

production and characterization of extracellular vesicles

Cryo-EM

characterization of extracellular vesicles from MSCs

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1300,–

BM-MSC/TERT292
Cat#: CHT-063-0292

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Title

Go to Top